Lois Almadrones

3.6k total citations · 1 hit paper
62 papers, 2.7k citations indexed

About

Lois Almadrones is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Lois Almadrones has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Reproductive Medicine, 32 papers in Surgery and 20 papers in Oncology. Recurrent topics in Lois Almadrones's work include Ovarian cancer diagnosis and treatment (33 papers), Intraperitoneal and Appendiceal Malignancies (22 papers) and Testicular diseases and treatments (16 papers). Lois Almadrones is often cited by papers focused on Ovarian cancer diagnosis and treatment (33 papers), Intraperitoneal and Appendiceal Malignancies (22 papers) and Testicular diseases and treatments (16 papers). Lois Almadrones collaborates with scholars based in United States and Chile. Lois Almadrones's co-authors include Stephen C. Rubin, William J. Hoskins, Bonnie Reichman, Thomas B. Hakes, John L. Lewis, Maurie Markman, Wanda K. Jones, Robert Rothman, John P. Curtin and Walter B. Jones and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Lois Almadrones

58 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

1991 647 citations Maurie Markman, Robert Rothman et al. Journal of Clinical Oncology profile →

Peers

Lois Almadrones

SURGE

ONCOL

PFM

Bonnie Reichman United States

K. Bertelsen Denmark

Jacobus Pfisterer Germany

Barbara Schmalfeldt Germany

Earl A. Surwit United States

Howard G. Muntz United States

C. Mangioni Italy

Giovanna Scarfone Italy

Stefano Greggi Italy

Atsuhiko Sakamoto Japan

Bonnie Reichman United States

Lois Almadrones

1.7k ×0.9

1.7k ×1.3

SURGE

1.7k ×1.8

ONCOL

468 ×0.7

398 ×1.2

PFM

Citations per year, relative to Lois Almadrones Lois Almadrones (= 1×) peers Bonnie Reichman

Countries citing papers authored by Lois Almadrones

Since Specialization

Citations

This map shows the geographic impact of Lois Almadrones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois Almadrones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois Almadrones more than expected).

Fields of papers citing papers by Lois Almadrones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois Almadrones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois Almadrones. The network helps show where Lois Almadrones may publish in the future.

Co-authorship network of co-authors of Lois Almadrones

This figure shows the co-authorship network connecting the top 25 collaborators of Lois Almadrones. A scholar is included among the top collaborators of Lois Almadrones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois Almadrones. Lois Almadrones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markman, Maurie, John L. Lewis, Patricia E. Saigo, et al.. (2010). Epithelial ovarian cancer in the elderly: The memorial sloan-kettering cancer center experience. Cancer. 71(S2). 634–637. 14 indexed citations

Makhija, Sharmila, Mario M. Leitão, Paul Sabbatini, et al.. (2001). Complications Associated with Intraperitoneal Chemotherapy Catheters. Gynecologic Oncology. 81(1). 77–81. 79 indexed citations

Barakat, Richard R., Lois Almadrones, E. S. Venkatraman, et al.. (1998). A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment. Gynecologic Oncology. 69(1). 17–22. 66 indexed citations

Markman, M, Thomas Hakes, R. Barakat, et al.. (1996). Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.. Journal of Clinical Oncology. 14(3). 796–799. 38 indexed citations

Curtin, John P., William J. Hoskins, Ennapadam Venkatraman, et al.. (1996). Adjuvant Chemotherapy versus Chemotherapy plus Pelvic Irradiation for High-Risk Cervical Cancer Patients after Radical Hysterectomy and Pelvic Lymphadenectomy (RH-PLND): A Randomized Phase III Trial. Gynecologic Oncology. 61(1). 3–10. 71 indexed citations

Almadrones, Lois, et al.. (1995). Arterial, peritoneal, and intraventricular access devices. Seminars in Oncology Nursing. 11(3). 194–202. 2 indexed citations

Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1993). The Use of Recombinant Human Erythropoietin to Prevent Carboplatin-Induced Anemia. Gynecologic Oncology. 49(2). 172–176. 29 indexed citations

Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1993). Mitomycin-C Plus a 3-Day Continuous Intravenous Infusion of 5-Fluorouracil: An Inactive Salvage Regimen for Platinum-Resistant Ovarian Carcinoma. Gynecologic Oncology. 50(1). 30–33.

Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.. Journal of Clinical Oncology. 10(9). 1479–1484. 63 indexed citations

10.

Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer. Gynecologic Oncology. 47(3). 353–357. 10 indexed citations

11.

Markman, M, Thomas B. Hakes, Bonnie Reichman, et al.. (1992). Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.. Journal of Clinical Oncology. 10(2). 243–248. 108 indexed citations

12.

Hakes, Thomas B., W.J. Hoskins, Walter B. Jones, et al.. (1992). Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Gynecologic Oncology. 45(3). 284–289. 120 indexed citations

13.

Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy. Journal of Cancer Research and Clinical Oncology. 118(5). 391–394. 1 indexed citations

14.

Markman, Maurie, Robert Rothman, Thomas B. Hakes, et al.. (1991). Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.. Journal of Clinical Oncology. 9(3). 389–393. 647 indexed citations breakdown →

15.

Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1991). Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.. Journal of Clinical Oncology. 9(10). 1801–1805. 143 indexed citations

16.

Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1991). Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy. Gynecologic Oncology. 43(2). 159–163. 13 indexed citations

17.

Markman, Maurie, Thomas B. Hakes, Bonnie Reichman, et al.. (1991). Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.. Journal of Clinical Oncology. 9(2). 204–210. 33 indexed citations

18.

Rubin, Stephen C., William J. Hoskins, Walter B. Jones, et al.. (1990). Aggressive chemosurgical debulking in patients with advanced ovarian cancer. Gynecologic Oncology. 38(3). 358–363. 26 indexed citations

19.

Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1989). Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.. Journal of Clinical Oncology. 7(9). 1327–1332. 68 indexed citations

20.

Hoskins, William J., Stephen C. Rubin, Douglas Chapman, et al.. (1989). Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecologic Oncology. 34(3). 365–371. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact